33296 Federal Register / Vol. 86, No. 119 / Thursday, June 24, 2021 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Participants in survey group examining POC NAT acceptability.POC NAT acceptability survey ........ 117 1 20/60 

Participants in cross-sectional comparison of several 

point-of-care NATs.

Release of information form ............ 333 1 10/60 

Study visit survey ............................. 333 1 15/60 

Acceptability/feasibility assessment among clinical and 

community providers.

POC NAT acceptability survey, 

focus group, or interview.

33 1 1 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–13434 Filed 6–23–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Needs and Challenges in Personal 

Protective Equipment (PPE) Use for 

Underserved User Populations 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Request for information. 

SUMMARY: NIOSH requests information 

on the Needs and Challenges in 

Personal Protective Equipment (PPE) 

Use for Underserved User Populations. 

DATES: Submit a letter of information by 

August 23, 2021. 

ADDRESSES: Interested parties should 

submit information to: NIOSH, Attn: 

Sherri Diana, National Institute for 

Occupational Safety and Health, NIOSH 

Docket Office, 1090 Tusculum Avenue, 

MS C–34, Cincinnati, Ohio 45226–1998, 

Email address: ppeconcerns@cdc.gov. 

FOR FURTHER INFORMATION CONTACT: N. 

Katherine Yoon, Ph.D., National 

Institute for Occupational Safety and 

Health, Centers for Disease Control and 

Prevention, Email Address: NYoon@

cdc.gov, Phone number: 412–386–6752 

[non-toll-free number] 

SUPPLEMENTARY INFORMATION: 

Background: The NIOSH National 

Personal Protective Technology 

Laboratory (NPPTL) is expanding its 

portfolio to include activities that 

consider the needs of U.S. worker 

populations who are underserved 

related to personal protective equipment 

(PPE) use, availability, accessibility, 

acceptability, or knowledge. 

Underserved PPE user populations may 

include, but are not limited to, workers 

who are of an atypical size; who are 

members of a gender, racial, ethnic, or 

linguistic minority group; who conduct 

non-traditional worker activities; or who 

are members of sub-disciplines that are 

not the primary focus of the current PPE 

activities within their larger field. To 

inform the possible design and 

execution of these activities, NPPTL 

seeks information from the public, 

including individuals/organizations 

who/that (1) advocate for these worker 

populations, (2) actively conduct PPE 

research, services, or policymaking for 

these worker populations, (3) are 

planning to conduct PPE research, 

services, or policymaking for these 

worker populations, (4) have direct 

knowledge about research, service, or 

policy gaps affecting these worker 

populations, or (5) are current or former 

PPE users that experienced PPE use, 

availability, accessibility, acceptability, 

or knowledge issues. 

Information Needs: CDC is 

particularly interested in receiving 

information being sought in Request (1). 

As such, responders are requested to 

provide information responsive to 

Request (1), and may address any or all 

of the topics identified in Requests (2) 

and (3): 

Request (1) Describe respondent(s) 

i. Individual or company/institution 

name, location, and website (if any) 

ii. Individual or company/institution 

contact information (include the 

respondent’s role in the organization, 

address, phone number, and email 

address) 

iii. The primary motivation(s) for why 

you (or your organization) are 

responding to this Notice 

iv. Any additional relevant 

background information about yourself 

or your organization as well as names of 

any other organizations currently 

working in applicable issues 

Request (2) Describe your experiences 

related to PPE use, availability, 

accessibility, acceptability, and 

knowledge issues for underserved PPE 

user populations within the U.S. (e.g., 

individuals of small or large size; 

members of gender, racial, ethnic or 

other minority group of a specific 

occupation, non-traditional workers, 

etc.) 

i. What experiences have you had in 

recent years related to PPE use, 

availability, accessibility, acceptability, 

and knowledge issues for underserved 

PPE user populations? Also, specify and 

describe the underserved PPE user 

group(s) with which you have had 

experience. 

ii. What data/information/resources 

did you find to be the most relevant/ 

valuable to the experiences described in 

Request 2(i)? 

iii. How long have you or your 

organization been working in the areas 

of work identified in Request 2(i)? Did 

your or your organization’s involvement 

change over time, and if so, how and 

why? 

iv. What achievements were a result 

of your work in PPE use, availability, 

accessibility, acceptability, and 

knowledge for underserved PPE user 

populations? (e.g., publications, 

guidance, new/revised policies or 

procedures, establishment of a key 

committee) 

v. What is your future work plan on 

PPE use, availability, accessibility, and 

knowledge for underserved PPE user 

populations? 

Request (3) Describe PPE gaps/barriers 

that remain to be addressed for 

underserved PPE user populations 

within the U.S. related to PPE use, 

availability, accessibility, acceptability, 

and knowledge issues (if any) 

i. What research gaps/barriers remain 

to be addressed? 

ii. What service gaps/barriers remain 

to be addressed? 

iii. What policy gaps/barriers remain 

to be addressed? 

Informational submissions in 

response to this Notice are due no later 

than August 23, 2021. Please limit 

informational submission to three pages 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 119 / Thursday, June 24, 2021 / Notices 33297 

or less in 12-point font, single-spaced. 

NIOSH will not respond to individual 

informational submissions nor publish 

publicly a compendium of responses. 

An informational submission in 

response to this Notice does not create 

any commitment on or behalf of CDC or 

HHS to develop or pursue any program 

or ideas discussed herein or related to 

PPE use for underserved user 

populations more generally. 

Disclaimer and Important Notes 

This Federal Register Notice is for 

planning purposes; it does not 

constitute a formal announcement for 

comprehensive applications. In 

accordance with Federal Acquisition 

Regulation 48 CFR 15.201(e), responses 

to this Notice are not offers and cannot 

be accepted by the Government to form 

a binding award. NIOSH will not 

provide reimbursement for costs 

incurred in responding to this Notice. 

John J. Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 2021–13263 Filed 6–23–21; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–21–1266] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘HIV 

prevention among Latina transgender 

women who have sex with men: 

Evaluation of a locally developed 

intervention’’ to the Office of 

Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on February 

25, 2021 to obtain comments from the 

public and affected agencies. CDC 

received one comment related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

HIV prevention among Latina 

transgender women who have sex with 

men: Evaluation of a locally developed 

intervention (OMB Control No. 0920– 

1266, Exp. 6/30/2021)—Revision— 

National Center for HIV/AIDS, Viral 

Hepatitis, STD and TB Prevention 

(NCHHSTP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

The National Center for HIV/AIDS, 

Viral Hepatitis, STD and TB Prevention 

(NCHHSTP) is requesting approval for a 

two-year extension of a currently 

approved ICR (OMB Control No. 0920– 

1266), titled ‘‘HIV prevention among 

Latina transgender women who have 

sex with men: Evaluation of a locally 

developed intervention.’’ The goal of 

this study is to evaluate the efficacy of 

ChiCAS (Chicas Creando Acceso a la 

Salud [Chicas: Girls Creating Access to 

Health]), a locally developed and 

culturally congruent two-session 

Spanish-language small-group 

combination intervention, designed to 

promote consistent condom use, and 

access to, and participation in, preexposure prophylaxis (PrEP) and 

medically supervised hormone therapy 

by HIV seronegative Hispanic/Latina 

transgender women who have sex with 

men. 

The information collected through 

this study will be used to evaluate 

whether the ChiCAS intervention is an 

effective HIV-prevention strategy by 

assessing whether exposure to the 

intervention results in improvements in 

participants’ health and HIV prevention 

behaviors. The study will compare pre- 

(baseline) and post-intervention (sixmonth) levels of HIV risk among 

participants who have received the 

intervention and participants who have 

not yet received the intervention 

(delayed-intervention group). 

This study will be carried out in 

metropolitan areas in and around North 

Carolina, including Ashville, NC; 

Charlotte, NC; Research Triangle 

(metropolitan area of Greensboro, 

Winston-Salem and High Point NC); 

Raleigh, NC; Wilmington, NC; and 

Greenville, SC. The study population 

will include 140 HIV-negative Spanishspeaking transgender women. 

Participants will be adults, at least 18 

years of age, self-identify as male-tofemale transgender or report having 

been born male and identifying as 

female, and report having sex with at 

least one man in the past six months. 

We anticipate participants will be 

comprised mainly of racial/ethnic 

minority participants under 35 years of 

age, consistent with the epidemiology of 

HIV infection among transgender 

women. 

Intervention participants will be 

recruited to the study through a 

combination of approaches, including 

traditional print advertisement, referral, 

in-person outreach, and through word of 

mouth. A quantitative assessment will 

be used to collect information for this 

study, which will be delivered at the 

time of study enrollment, and again at 

a six-month follow up. The assessment 

will be used to measure differences in 

sexual risk knowledge, perceptions and 

behaviors including condom use, PrEP 

use, and use of medically supervised 

hormone therapy. Intervention 

mediators, including healthcare 

provider trust and communication 

skills, self-reported health status and 

healthcare access, community 

attachment and social support will also 

be measured. All participants will 

complete an assessment at baseline and 


khammond on DSKJM1Z7X2PROD with NOTICES